Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Broker TP ICAP slips as first-half profit falls* UK PM raises taxes to tackle health crisis* 888 in talks to buy William Hill's non-U.S. as...
Read more
TOP NEWS: Glaxo and partner start late-stage trial of Covid-19 vaccine
Read moreLONDON MARKET PRE-OPEN: Bunzl raises dividend after strong results
Read more* SK Bioscience candidate combines vaccine booster from GSK* Results from study expected in first half of 2022* SK Bioscience vaccine is S. Korea's first domestic shot (Adds detail throughout)By Pushkala AripakaAug 31 (Reuters) - South Korea's SK Bi...
Read more
(Sharecast News) - South Korea's SK Bioscience and the UK's GlaxoSmithKline on Tuesday said they would start a phase 3 clinical study of SK's Covid-19 vaccine candidate combined with GSK's pandemic vaccine booster
Read more(Sharecast News) - South Korea's SK Bioscience and the UK's GlaxoSmithKline on Tuesday said they would start a phase 3 clinical study of SK's Covid-19 vaccine candidate combined with GSK's pandemic vaccine booster
Read moreLONDON BROKER RATINGS: Berenberg ups price targets on Flutter, Entain
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rio Tinto jumps on restarting operations at Richards Bay* Engineering firm Wood drops on lower annual earnings forecast* Mid-caps hit reco...
Read more* Astra in frame to launch new prevention tool on top of vaccines* Antibody combo 77% effective in preventing COVID-19* New hope for immunocompromised with low vaccine protection* AstraZeneca pursuing initial approval well before year-end* (Adds ex...
Read more* Antibody combo 77% effective in preventing COVID-19* New hope for immunocompromised with low vaccine protection* AstraZeneca pursuing initial approval well before year-end (Adds further development, expected review, strategic implications)By Ludw...
Read moreBy Caroline CopleyBERLIN, Aug 19 (Reuters) - German contract drug manufacturer Rentschler Biopharma is in final preparations to start commercial production of CureVac's COVID-19 vaccine, its chief executive said, despite uncertainty over whether t...
Read more(Sharecast News) - Empiric Student: Berenberg downgrades to hold with 100.0p target price.
Read moreLONDON BROKER RATINGS: Berenberg ups Future price target after US deal
Read more(Sharecast News) - Future: ShoreCap stays at buy; Deutsche Bank keeps at buy and raises target price from 3,802.0p to 4,138.0p.
Read more(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...
Read more
Last checked at